| pubmed-article:8452574 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8452574 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
| pubmed-article:8452574 | lifeskim:mentions | umls-concept:C0205345 | lld:lifeskim |
| pubmed-article:8452574 | lifeskim:mentions | umls-concept:C0242708 | lld:lifeskim |
| pubmed-article:8452574 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:8452574 | pubmed:dateCreated | 1993-4-12 | lld:pubmed |
| pubmed-article:8452574 | pubmed:abstractText | To compare the toxicities of commonly employed disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis (RA). | lld:pubmed |
| pubmed-article:8452574 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8452574 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8452574 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8452574 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8452574 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8452574 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8452574 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8452574 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8452574 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8452574 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8452574 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8452574 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8452574 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:8452574 | pubmed:issn | 0004-3591 | lld:pubmed |
| pubmed-article:8452574 | pubmed:author | pubmed-author:WilliamsC ACA | lld:pubmed |
| pubmed-article:8452574 | pubmed:author | pubmed-author:FriesJ FJF | lld:pubmed |
| pubmed-article:8452574 | pubmed:author | pubmed-author:BlochD ADA | lld:pubmed |
| pubmed-article:8452574 | pubmed:author | pubmed-author:RameyDD | lld:pubmed |
| pubmed-article:8452574 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8452574 | pubmed:volume | 36 | lld:pubmed |
| pubmed-article:8452574 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8452574 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8452574 | pubmed:pagination | 297-306 | lld:pubmed |
| pubmed-article:8452574 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
| pubmed-article:8452574 | pubmed:meshHeading | pubmed-meshheading:8452574-... | lld:pubmed |
| pubmed-article:8452574 | pubmed:meshHeading | pubmed-meshheading:8452574-... | lld:pubmed |
| pubmed-article:8452574 | pubmed:meshHeading | pubmed-meshheading:8452574-... | lld:pubmed |
| pubmed-article:8452574 | pubmed:meshHeading | pubmed-meshheading:8452574-... | lld:pubmed |
| pubmed-article:8452574 | pubmed:meshHeading | pubmed-meshheading:8452574-... | lld:pubmed |
| pubmed-article:8452574 | pubmed:meshHeading | pubmed-meshheading:8452574-... | lld:pubmed |
| pubmed-article:8452574 | pubmed:meshHeading | pubmed-meshheading:8452574-... | lld:pubmed |
| pubmed-article:8452574 | pubmed:meshHeading | pubmed-meshheading:8452574-... | lld:pubmed |
| pubmed-article:8452574 | pubmed:meshHeading | pubmed-meshheading:8452574-... | lld:pubmed |
| pubmed-article:8452574 | pubmed:meshHeading | pubmed-meshheading:8452574-... | lld:pubmed |
| pubmed-article:8452574 | pubmed:meshHeading | pubmed-meshheading:8452574-... | lld:pubmed |
| pubmed-article:8452574 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8452574 | pubmed:articleTitle | The relative toxicity of disease-modifying antirheumatic drugs. | lld:pubmed |
| pubmed-article:8452574 | pubmed:affiliation | Department of Medicine, Stanford University School of Medicine, California. | lld:pubmed |
| pubmed-article:8452574 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8452574 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8452574 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:8452574 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:8452574 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:8452574 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8452574 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8452574 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8452574 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8452574 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8452574 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8452574 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8452574 | lld:pubmed |
